JP2016521286A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521286A5
JP2016521286A5 JP2016513125A JP2016513125A JP2016521286A5 JP 2016521286 A5 JP2016521286 A5 JP 2016521286A5 JP 2016513125 A JP2016513125 A JP 2016513125A JP 2016513125 A JP2016513125 A JP 2016513125A JP 2016521286 A5 JP2016521286 A5 JP 2016521286A5
Authority
JP
Japan
Prior art keywords
weeks
nutritional supplement
lipid
cancer
diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016521286A (ja
JP6533519B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037514 external-priority patent/WO2014183047A1/en
Publication of JP2016521286A publication Critical patent/JP2016521286A/ja
Publication of JP2016521286A5 publication Critical patent/JP2016521286A5/ja
Priority to JP2019097670A priority Critical patent/JP6970709B2/ja
Application granted granted Critical
Publication of JP6533519B2 publication Critical patent/JP6533519B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513125A 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉 Active JP6533519B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019097670A JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822095P 2013-05-10 2013-05-10
US61/822,095 2013-05-10
PCT/US2014/037514 WO2014183047A1 (en) 2013-05-10 2014-05-09 Lipid scavenging in ras cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019097670A Division JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Publications (3)

Publication Number Publication Date
JP2016521286A JP2016521286A (ja) 2016-07-21
JP2016521286A5 true JP2016521286A5 (enExample) 2017-06-15
JP6533519B2 JP6533519B2 (ja) 2019-06-19

Family

ID=51867773

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513125A Active JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉
JP2019097670A Expired - Fee Related JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019097670A Expired - Fee Related JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Country Status (7)

Country Link
US (2) US10130600B2 (enExample)
EP (1) EP2993980B1 (enExample)
JP (2) JP6533519B2 (enExample)
AU (3) AU2014262450A1 (enExample)
CA (2) CA3136947C (enExample)
IL (2) IL242492B (enExample)
WO (1) WO2014183047A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
EP2968988A4 (en) 2013-03-14 2016-11-16 Allegro Diagnostics Corp METHOD FOR EVALUATING A COPD STATUS
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
US11369588B2 (en) 2014-03-20 2022-06-28 The Trustees Of Princeton University NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
AU2018230784A1 (en) 2017-03-09 2019-10-10 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
US12653836B2 (en) 2020-07-15 2026-06-16 The Trustees Of Princeton University Ketogenic diet and ketone supplementation for cancer therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183815T3 (es) 1992-07-24 2003-04-01 Univ Johns Hopkins Quimioterapia para el cancer.
EP0929694A4 (en) * 1996-03-15 2002-05-02 Penn State Res Found DETECTION OF TUMOR-RELATED EXTRACELLULAR NUCLEIC ACID USING PLASMA OR BLOOD SERUM USING NUCLEIC ACID AMPLIFICATION TESTS
US6214875B1 (en) 1998-04-14 2001-04-10 Zhenhua Yang Anticancer effects of specific branched-chain fatty acids and related production process
JP5511126B2 (ja) 2003-03-27 2014-06-04 サントリーホールディングス株式会社 脂質改善剤及び脂質改善剤を含んでなる組成物
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
WO2008147562A2 (en) * 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
WO2012165345A1 (ja) * 2011-05-27 2012-12-06 株式会社明治 がんに伴う不可逆性の代謝障害の予防及び/又は改善のための組成物
CN103608023A (zh) 2011-06-15 2014-02-26 稳定解决方案有限责任公司 磷虾油的胃肠外治疗应用
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers

Similar Documents

Publication Publication Date Title
Chen et al. Fish oil attenuates liver injury caused by LPS in weaned pigs associated with inhibition of TLR4 and nucleotide-binding oligomerization domain protein signaling pathways
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
JP2019147836A5 (enExample)
ES2810323T3 (es) Agente antiinflamatorio que contiene ácido graso raro
MX388553B (es) Composiciones nutritivas de triglicèridos de cadena media para la protección de la vàlvula mitral en animales de compañìa.
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
MX2016006675A (es) Producción de ácidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa de pufa proveniente de traustoquitridio.
Jung et al. Quality assessment of the breast meat from WoorimatdagTM and broilers
CA2905817A1 (en) Reducing the risk of autoimmune disease
Zuo et al. Molecular cloning, tissue distribution and nutritional regulation of a Δ6‐fatty acyl desaturase‐like enzyme in large yellow croaker (L arimichthys crocea)
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
MX2015012548A (es) Metodos para estimular la maduracion de pulmones e intestinos infantiles.
Shu et al. Effect of ascorbic acid and cysteine hydrochloride on growth of Bifidobacterium bifidum
WO2017132445A8 (en) Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitor
Minarny et al. Fatty acid profile of fish from Central Sulawesi, Indonesia.
SG10201903120YA (en) Nutritional composition comprising whey and hydrolyzed casein and uses thereof
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
UA86387U (ru) Способ оценки эффективности лечения больных с артериальной гипертензией, объединенной с метаболическим синдромом
Yoshii et al. Impact of EPA nutritional approach on cachexic patients with advanced hypopharyngeal cancer treated by induction chemotherapy
Jorjani et al. Comparison of Chemical Compositions and Fatty Acid Profile of Cultured Common Carp (Cyprinus carpio) and Silver Carp (Hypophthalmichthys molitrix)
林雪麗 et al. Duckweed (Lemna minor), as a potential protein source for red tilapia (Oreochromis sp.)